dr. crafton on considerations for secondary cytoreduction in ovarian cancer
Published 4 years ago • 122 plays • Length 0:49Download video MP4
Download video MP3
Similar videos
-
1:07
dr. crafton on secondary surgical cytoreduction in ovarian cancer
-
1:22
dr. crafton on optimizing treatment selection in recurrent ovarian cancer
-
0:58
dr. crafton on the impact of parp inhibitors in recurrent ovarian cancer
-
1:23
dr. sehouli on considering secondary cytoreductive surgery in ovarian cancer
-
1:29
dr. fowler on patient eligibility for cytoreductive surgery in ovarian cancer
-
2:50
secondary debulking in recurrent ovarian cancer
-
2:15
dr. sehouli discusses trial of secondary cytoreductive surgery in ovarian cancer
-
1:09
dr. arend on unmet needs in platinum-resistant ovarian cancer
-
2:05
dr. copeland on the etiology of ovarian cancer
-
5:27
recurrent ovarian cancer; considerations beyond the platinum-free interval
-
23:15
is it time to change upfront chemotherapy for ovarian cancer?
-
1:34
dr. birrer discusses recurrent ovarian cancer treatment
-
3:22
novel combination strategies in recurrent ovarian cancer
-
7:26
emerging therapies in recurrent ovarian cancer
-
1:15
dr. konner on parp inhibitors in ovarian cancer
-
0:56
dr. crane on combinations with parp inhibitors in ovarian cancer
-
1:49
dr. konstantinopoulos on immunotherapy in ovarian cancer
-
3:06
recurrent ovarian cancer: choosing a parp inhibitor
-
1:48
dr. secord on using biomarkers to guide treatment decisions in ovarian cancer